Navigation Links
Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
Date:9/23/2011

NEW YORK and STOCKHOLM, September 23, 2011 /PRNewswire/ --

March 2011 Data Confirm Strong Treatment Effect of Chemosaturation

Delcath Systems (NASDAQ: DCTH) announced today that James F. Pingpank, MD, FACS, Associate Professor of Surgery at the University of Pittsburgh School of Medicine, will present updated investigator results from the Phase 3 randomized trial of Delcath's chemosaturation system with melphalan in patients with hepatic metastases from ocular or cutaneous melanoma.

Dr. Pingpank, a lead principal investigator of the Phase 3 trial, will present the abstract (9304), "Percutaneous Hepatic Perfusion (PHP) vs. Best Alternative Care (BAC) for Patients with Melanoma Liver Metastases - Efficacy Update of the Phase 3 Trial,"  in the plenary session today at 11:15am CEST at the European Multidisciplinary Cancer Congress in Stockholm. These updated results include follow-up data from patients through March 2011, an additional 12 months of data maturation from when Dr. Pingpank first presented investigator data from this Phase 3 trial in June 2010, at the American Society of Clinical Oncology's Annual Meeting.

With respect to the study's primary endpoint of hepatic progression free survival ("hPFS"), the updated investigator-assessed results showed that patients in the chemosaturation arm demonstrated median hPFS of 8.0 months compared to 1.6 months in the BAC arm, a significant 6.4 month extension of hPFS (hazard ratio 0.35, p<0.0001). Median overall PFS in the chemosaturation arm was 6.7 months compared to 1.6 months in the BAC arm, an increase of 5.1 months (hazard ratio 0.36, p<0.0001).  

As reported previously, the hepatic response rate in the chemosaturation arm was 34% compared to 2% for the BAC arm. In addition, 52% of patients in the chemosaturation arm achieved stable disease, compared with 27% in the BAC group, givin
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
2. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
3. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
4. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
5. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
6. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
7. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
8. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
9. Delcath on Preliminary List of Additions to Russell Microcap® Index
10. Delcath to Present at the JMP Securities Research Conference
11. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical ... announced that it has entered into a $20 million ... HTGC).  The loan agreement includes both a $5 million ... term loan. Proceeds are expected to be ...
... Aug. 8, 2011 Global Health Ventures Inc. ... on sublingual drug delivery announced today that their August ... and CEO, is available for on-demand viewing. ... watch event now" button. Their presentation will ...
Cached Medicine Technology:NeurogesX, Inc. Secures $20 Million Debt Facility 2NeurogesX, Inc. Secures $20 Million Debt Facility 3NeurogesX, Inc. Secures $20 Million Debt Facility 4Global Health Ventures August 4th Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for ... its latest collection of wedding dresses , and launches ... is the wedding dress on your big day; the wedding ... Every bride wants to find the most suitable wedding dress. ...
(Date:1/22/2015)... Step into a macabre world where plants ... Virginia. Wicked Plants, the Museum’s latest featured exhibition, opens ... carnivorous and diabolical plants inside of a dilapidated, Victorian ... biochemical, physical and neurological processes between botanicals and the ...
(Date:12/26/2014)... It is said that nothing makes a lady feel ... wedding dress supplier, shows its new selection of navy ... , UWDress.com’s navy cocktail gowns are the cornerstones of ... fashion styles. Simple dresses in bright neon colors can be ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... and Industry Thought Leader Joins Healthcare ... Management Consulting Practice, ... to announce the appointment of Ogan Gurel, M.D. as a ... have Dr. Gurel join our team," said Vip Jain - ...
... BET Networks, national HIV/AIDS,public awareness initiative Rap-It-Up returns ... health forums throughout New York City and Newark,N.J., to ... young adults; as well as the rise of HIV/AIDS ... organization Hip,Hop 4 Life and local radio station Hot ...
... to succeed in reducing prevalance of obesity,among children ... intervention and,education, MEMPHIS, Tenn., Nov. 7 ... at St. Jude Children,s,Research Hospital is the first ... in reducing the prevalence of overweight children, according ...
... businesses for its commitment to building a culture of ... ... The American Heart Association,recently recognized Regence as a Start! ... in the workplace and helping,employees live healthier lives. The company ...
... Million ... Million, SUNNYVALE, Calif., Nov. 7 Accuray,Incorporated (Nasdaq: ... announced financial results for the first quarter of fiscal 2008,ended ... 2008, Accuray reported record total,revenue of $48.6 million, up 48 ...
... ... Exploration Process, GERMANTOWN, Md., Nov. ... company focused on,developing and commercializing novel anti-infective products, announced an,agreement ... Company,s largest equity shareholders, raising up to $10 million in,cash. ...
Cached Medicine News:Health News:XRoads Solutions Group Appoints Dr. Ogan Gurel as Managing Director 2Health News:BET Networks' Award-Winning Rap-It-Up HIV/AIDS Campaign Returns to New York City for The Youth Empowerment Tour on November 13-16 2Health News:BET Networks' Award-Winning Rap-It-Up HIV/AIDS Campaign Returns to New York City for The Youth Empowerment Tour on November 13-16 3Health News:St. Jude Program Reduces Weight Gain in Young African-American Girls 2Health News:St. Jude Program Reduces Weight Gain in Young African-American Girls 3Health News:American Heart Association Award Recognizes Regence as a Start! Fit-Friendly Company 2Health News:American Heart Association Award Recognizes Regence as a Start! Fit-Friendly Company 3Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 2Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 3Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 4Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 5Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 6Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 7Health News:Accuray Reports Record Revenue in First Quarter of Fiscal 2008 8Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 2Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 3Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 4Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 5
... Bio-Quant S. typhi rapid test is ... The test employs a conation of ... polyclonal antibody immobilized on the solid ... typhi,antigen associated Salmonella typhi (typhoid) infection ...
... Mono is an immunochromatographic in vitro ... with,infectious mononucleosis infection.,Infectious mononucleosis (IM) is ... of IM is based on detection ... such as the,heterophile antibodies present in ...
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
... Myoglobin Insta Test is an ... test. It is designed for ... serum specimens. The presence of ... ng/mL or higher can be ...
Medicine Products: